drugset / Trial / NCT06864884
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
RandomizedParallel-groupTriple-blindTreatment
Summary
The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side effects?
Timeline
- Start
- 2025-02-26
- Primary completion
- 2026-02
- Completion
- 2026-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARC-001 | Unknown | 0.75 ml | Topical |